Agomab
BelgiumEntry
2021
Hold
5yr
Exit
2026
Who owns Agomab?
Agomab was owned by Asabys Partners through Sabadell Asabys Health Innovation Investments (2019 vintage) from 2021 to 2026, exited via IPO. Across its history, Agomab has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Asabys PartnersSabadell Asabys Health Innovation Investments · 2019 · Life Sciences VC
2 ownership periods · full history below
Key facts
Key takeaways
- ·Fully exited in 2026.
- ·Average hold across 2 realized cycles: 6 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2026 to .
Co-invest · 2 holders · 2019 · 2026
Asabys PartnersExited 2026
2021 · 2026(5yr) · Sabadell Asabys Health Innovation Investments · 2019 · Life Sciences VC
IPO
MOIC
–
More from Sabadell Asabys Health Innovation Investments
Other portfolio companies in the same fund.
Spain
United StatesMore PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
FranceTrack AgoMab
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on AgoMab.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue